|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Amarin Pharma Inc.
| | | Phone: | (908) 719-1315 | Fax: | (908) 719-3012 | Year Established: | 1989 | Ticker: | AMRN | Exchange: | NASDAQ | Main Contact: | Aaron Berg, Senior VP & CCO | | Other Contacts: | Craig Granowitz, MD, PhD,, Senior VP & CMO Steven Ketchum, Ph.D., President, R&D John Thero, President & CEO Joseph T. Kennedy, Executive VP, General Counsel & Strategic Initiatives Michael W. Kalb, Senior VP & CFO
| | Company Description | Amarin (formerly Ethical Holdings) is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepaź (icosapent ethyl), Amarin's first FDA-approved product, is an ultra-pure, EPA-only omega-3 fatty acid product available by prescription. | |
|
|
|
|
|